Pharmacovigilance (PV) Industry Expert Announced As EphMRA 2018 Conference Keynote Speaker
PV industry expert Dr Phil Eichorn, Senior Director, Safety Evaluation & Reporting, Worldwide Safety & Regulatory, Pfizer Labs Ltd, will be delivering one of the keynote sessions at EphMRA’s 2018 Conference on Thursday 28th June.
A highly respected individual in the PV field, Dr Eichorn’s session will be an opportunity for delegates to hear the latest on current practices and regulations within the industry, and his wealth of experience makes his insights invaluable to both agencies and industry individuals alike.
Before joining the healthcare industry, Dr Phil Eichorn underwent his medical training in the US, practising general adult medicine in both outpatient and hospital settings for 10 years. Following his arrival at Pfizer (UK) in 2002, he has served a wide variety of roles in the safety, risk management, and regulatory defamation functions. Most recently, his role has been to support market research and other customer outreach programmes from a safety perspective.
Topics set to be covered by Phil include:
- The role of PV with regards to AE reporting
- What PV require from MR AE reporting and why
- PV frustrations versus MR frustrations
Variations in PV requirements by country
- Implications of the EMA relocation for AE reporting processes
- Risks associated with divergence and duplication of regulatory standards and practices
- Non-EY requirements (USA, Japan etc.)
Be sure you don’t miss out on this opportunity to hear this industry expert and his invaluable insights by registering for the event on January 22nd. EphMRA’s 2018 Conference takes place in Basel Congress Centre, Basel, from 26-28 June.